Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actin-myosin interaction

Cardiovascular Research

Volumn 60, Issue 3, 2003, Pages 580-588

  Yamashita, Hiroshi ^a   Sugiura, Seiryo ^b   Fujita, Hideo ^a   Yasuda, So Ichiro ^a   Nagai, Ryozo ^a   Saeki, Yasutake ^c   Sunagawa, Kenji ^d   Sugi, Haruo ^e  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TSURUMI UNIVERSITY   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

Author keywords

Actin translocating velocity; ATPase activity; Cardiac myosin; In vitro motility assay; Laser trap; Myosin light chain; Unitary displacement; Unitary force

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE; CARDIAC MYOSIN; ISOPROTEIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN;

ACTIN MYOSIN INTERACTION; ALPHA CHAIN; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FORCE; HEART ATRIUM; HEART MUSCLE; HEART VENTRICLE; IN VITRO STUDY; MALE; MUSCLE LENGTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RAT; STRUCTURE ANALYSIS; TECHNIQUE; VELOCITY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MALE; MICROFILAMENTS; MYOCARDIUM; MYOSIN LIGHT CHAINS; MYOSINS; PROTEIN ISOFORMS; RATS; RATS, WISTAR;

EID: 0345059065     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.09.011     Document Type: Article

References (43)

1. Izumo S., Lompre A.M., Matsuoka R.et al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J. Clin. Invest. 79:1987;970-977.
2. Hoh J.F., McGrath P.A., Hale P.T. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol. 10:1978;1053-1076.
3. Schwartz K., Lecarpentier Y., Martin J.L., Lompre A.M., Mercadier J.J., Swynghedauw B. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J. Mol. Cell. Cardiol. 13:1981;1071-1075.
4. Alpert N.R., Mulieri L.A. Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit. A characterization of heat liberation in normal and hypertrophied right ventricular papillary muscles. Circ. Res. 50:1982;491-500.
5. Sugiura S., Kobayakawa N., Fujita H.et al. Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ. Res. 82:1998;1029-1034.
6. Palmiter K.A., Tyska M.J., Dupuis D.E., Alpert N.R., Warshaw D.M. Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms. J. Physiol. 519:1999;669-678.
7. Lowes B.D., Minobe W., Abraham W.T.et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J. Clin. Invest. 100:1997;2315-2324.
8. Miyata S., Minobe W., Bristow M.R., Leinwand L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86:2000;386-390.
9. Reiser P.J., Portman M.A., Ning X.H., Schomisch Moravec C. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am. J. Physiol, Heart Circ. Physiol. 280:2001;H1814-H1820.
10. Schaub M.C., Hefti M.A., Zuellig R.A., Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc. Res. 37:1998;381-404.
11. Hirzel H.O., Tuchschmid C.R., Schneider J., Krayenbuehl H.P., Schaub M.C. Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy. Circ. Res. 57:1985;729-740.
12. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J. Clin. Invest. 100:1997;2362-2370.
13. Morano I. Tuning the human heart molecular motors by myosin light chains. J. Mol. Med. 77:1999;544-555.
14. Tobacman L.S., Adelstein R.S. Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1. J. Biol. Chem. 259:1984;11226-11230.
15. Sutsch G., Brunner U.T., von Schulthess C.et al. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ. Res. 70:1992;1035-1043.
16. Morano M., Zacharzowski U., Maier M.et al. Regulation of human heart contractility by essential myosin light chain isoforms. J. Clin. Invest. 98:1996;467-473.
17. Yamashita H., Sata M., Sugiura S., Momomura S., Serizawa T., Iizuka M. ADP inhibits the sliding velocity of fluorescent actin filaments on cardiac and skeletal myosins. Circ. Res. 74:1994;1027-1033.
18. Yamashita H., Tyska M.J., Warshaw D.M., Lowey S., Trybus K.M. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. J. Biol. Chem. 275:2000;28045-28052.
19. Spudich J.A., Watt S. The regulation of rabbit skeletal muscle contraction: I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J. Biol. Chem. 246:1971;4866-4871.
20. Kurokawa H., Fujii W., Ohmi K., Sakurai T., Nonomura Y. Simple and rapid purification of brevin. Biochem. Biophys. Res. Commun. 168:1990;451-457.
21. Reiser P.J., Kline W.O. Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am. J. Physiol. 274:1998;H1048-H1053.
22. Perrie W.T., Perry S.V. An electrophoretic study of the low-molecular-weight components of myosin. Biochem. J. 119:1970;31-38.
23. Pemrick S.M. The phosphorylated L2 light chain of skeletal myosin is a modifier of the actomyosin ATPase. J. Biol. Chem. 255:1980;8836-8841.
24. Meeusen R.L., Cande W.Z. N-Ethylmaleimide-modified heavy meromyosin. A probe for actomyosin interactions. J. Cell Biol. 82:1979;57-65.
25. Kron S.J., Spudich J.A. Fluorescent actin filaments move on myosin fixed to a glass surface. Proc. Natl. Acad. Sci. U. S. A. 83:1986;6272-6276.
26. Sugiura S., Kobayakawa N., Momomura S., Chaen S., Omata M., Sugi H. Different cardiac myosin isoforms exhibit equal force-generating ability in vitro. Biochim. Biophys. Acta. 1273:1996;73-76.
27. Molloy J.E., Burns J.E., Kendrick-Jones J., Tregear R.T., White D.C. Movement and force produced by a single myosin head. Nature. 378:1995;209-212.
28. Lompre A.M., Schwartz K., d'Albis A., Lacombe G., Van Thiem N., Swynghedauw B. Myosin isoenzyme redistribution in chronic heart overload. Nature. 282:1979;105-107.
29. Bottinelli R., Canepari M., Cappelli V., Reggiani C. Maximum speed of shortening and ATPase activity in atrial and ventricular myocardia of hyperthyroid rats. Am. J. Physiol. 269:1995;C785-C790.
30. Wagner P.D. Formation and characterization of myosin hybrids containing essential light chains and heavy chains from different muscle myosins. J. Biol. Chem. 256:1981;2493-2498.
31. VanBuren P., Harris D.E., Alpert N.R., Warshaw D.M. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ. Res. 77:1995;439-444.
32. Fewell J.G., Hewett T.E., Sanbe A.et al. Functional significance of cardiac myosin essential light chain isoform switching in transgenic mice. J. Clin. Invest. 101:1998;2630-2639.
33. Sanbe A., Gulick J., Hayes E.et al. Myosin light chain replacement in the heart. Am. J. Physiol, Heart Circ. Physiol. 279:2000;H1355-H1364.
34. Siemankowski R.F., White H.D. Kinetics of the interaction between actin, ADP, and cardiac myosin-S1. J. Biol. Chem. 259:1984;5045-5053.
35. Andreev O.A., Borejdo J. Interaction of the heavy and light chains of cardiac myosin subfragment-1 with F-actin. Circ. Res. 81:1997;688-693.
36. Timson D.J., Trayer H.R., Smith K.J., Trayer I.P. Size and charge requirements for kinetic modulation and actin binding by alkali 1-type myosin essential light chains. J. Biol. Chem. 274:1999;18271-18277.
37. Morano I., Haase H. Different actin affinities of human cardiac essential myosin light chain isoforms. FEBS Lett. 408:1997;71-74.
38. Huxley A.F. Muscle structure and theories of contraction. Prog. Biophys. Biophys. Chem. 7:1957;255-318.
39. Rayment I., Rypniewski W.R., Schmidt-Base K.et al. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 261:1993;50-58.
40. Uyeda T.Q., Abramson P.D., Spudich J.A. The neck region of the myosin motor domain acts as a lever arm to generate movement. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4459-4464.
41. Lowey S., Waller G.S., Trybus K.M. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature. 365:1993;454-456.
42. Cummins P. Transitions in human atrial and ventricular myosin light-chain isoenzymes in response to cardiac-pressure-overload-induced hypertrophy. Biochem. J. 205:1982;195-204.
43. Trahair T., Yeoh T., Cartmill T.et al. Myosin light chain gene expression associated with disease states of the human heart. J. Mol. Cell. Cardiol. 25:1993;577-585.